![Rakesh Chhaganlal Tailor](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Rakesh Chhaganlal Tailor
Vorstandsvorsitzender bei Axonics Women's Health Ltd.
Ursprung des Netzwerks ersten Grades von Rakesh Chhaganlal Tailor
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Axonics Women's Health Ltd.
![]() Axonics Women's Health Ltd. Pharmaceuticals: MajorHealth Technology Contura Ltd. specializes in the distribution and sale of healthcare products, both in pharmaceuticals and medical devices. The firm focuses in the fields of urology and urogynaecology. Its products include bulkamid, cystistat, and aquamid. The company was founded by Henry Geoffrey McMillan in 2000 and is headquartered in London, the United Kingdom.
7
| Subsidiary | Pharmaceuticals: Major | 7 |
Axonics GmbH
![]() Axonics GmbH Pharmaceuticals: MajorHealth Technology Part of Axonics, Inc., Axonics GmbH engages in the development, manufacture, and clinical application of hydrogels. The company is based in Ratingen, Germany. The German company was founded in 2000. Patrick John Banks has been the CEO of the company since 2010.
5
| Subsidiary | Pharmaceuticals: Major | 5 |
Contura International A/S
![]() Contura International A/S Medical SpecialtiesHealth Technology Contura International A/S develops and markets soft tissue fillers to the healthcare industry. Its products include Bulkamid, a class leading urethral bulking agent for treatment of stress urinary incontinence; and Aquamid, an aesthetic injectable volumiser. The company was founded on March 1, 2000 and is headquartered in Søborg, Denmark.
4
| Subsidiary | Medical Specialties | 4 |
Pfizer Ltd.
![]() Pfizer Ltd. Pharmaceuticals: MajorHealth Technology Pfizer Ltd. is a biopharmaceutical company that develops and provides medicines, vaccines, and consumer healthcare products. Its products include prescription and counterfeit medicines, and over-the-counter products. The company was founded in 1952 and is headquartered in Tadworth, the United Kingdom.
3
| Subsidiary | Pharmaceuticals: Major | 3 |
Contura Holdings Ltd.
![]() Contura Holdings Ltd. Pharmaceuticals: MajorHealth Technology Contura Holdings Ltd. is a British pharmaceutical company that manufactures pharmaceutical products. The private company is based in London, UK. The company was founded in 2016.
3
| Private Company | Pharmaceuticals: Major | 3 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Rakesh Chhaganlal Tailor
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
ORTHOFIX MEDICAL INC. | Medical Specialties | Director/Board Member | |
BAYER AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
ERBA DIAGNOSTICS, INC. | Medical Specialties | Director/Board Member | |
Coley Pharmaceutical Group, Inc.
![]() Coley Pharmaceutical Group, Inc. Pharmaceuticals: MajorHealth Technology Coley Pharmaceutical Group, Inc. manufactures drugs to treat chronic diseases. The company discovers and develops receptors therapeutic candidates for cancers, asthma, and allergic disorders. It was founded in 1997 and is headquartered in Wellesley, MA | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
StemCyte, Inc.
![]() StemCyte, Inc. BiotechnologyHealth Technology StemCyte, Inc. operates as a biotechnology company that collects, banks and distributes cord blood stem cell transfusion units. It focuses on stem cell transplantation, therapy, applications, diagnostics, and genomic research. The firm uses insulated containers to keep your baby's cord blood cool throughout transport. The company was founded by Denis Rodgerson and Robert Chow in 1997 and is headquartered in Covina, CA. | Biotechnology | Corporate Officer/Principal | |
Advent Venture Partners LLP
![]() Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom. | Investment Managers | President Private Equity Investor | |
Phoqus Pharmaceuticals Plc
![]() Phoqus Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Phoqus Pharmaceuticals Plc develops pharmaceutical products. It's product Chronocort that helps to treat the patients with cortisol deficiency such as congenital adrenal hyperplasia and Addison's diseases. The company was founded in 1998 and is located in West Malling, UK. | Pharmaceuticals: Major | Director/Board Member | |
International Federation of Pharmaceutical Manufacturers
![]() International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | Biotechnology | Corporate Officer/Principal | |
Harvard University
![]() Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree | |
Stanford University | College/University | Masters Business Admin | |
University of Pennsylvania | College/University | Corporate Officer/Principal | |
Cutfield Freeman & Co. Ltd.
![]() Cutfield Freeman & Co. Ltd. Investment ManagersFinance Cutfield Freeman & Co. Ltd. provides independent advice on mining finance such as joint ventures, project finance, mergers and acquisitions, private fund raising, and corporate restructuring. The firm also develops and implements strategies to address complex mining finance challenges. The company was founded in 2000 and is headquartered in London, the United Kingdom. | Investment Managers | Corporate Officer/Principal | |
ALNYLAM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Phoqus Pharmaceuticals (UK) Ltd.
![]() Phoqus Pharmaceuticals (UK) Ltd. Pharmaceuticals: MajorHealth Technology Phoqus Pharmaceuticals (UK) Ltd. manufactures pharmaceuticals products. The firm develops advanced drug delivery systems. It conducts research & development on natural sciences and engineering. The company was founded on December 29, 1997 and is located in London, UK. | Pharmaceuticals: Major | Director/Board Member | |
University College London | College/University | Doctorate Degree | |
Amgen Rockville, Inc.
![]() Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD. | Biotechnology | Director/Board Member | |
Pharmaceutical Research & Manufacturers of America
![]() Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Chairman | |
European Federation of Pharmaceutical Industries & Assns
![]() European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
F2G Ltd.
![]() F2G Ltd. Pharmaceuticals: MajorHealth Technology F2G Ltd. provides novel drugs for the treatment of life-threatening systemic fungal diseases. It primarily focuses on developing an F3 series of anti mould compound, which is an antifungal agent that acts through a mechanism different from marketed drugs. The company was founded in 1998 and is headquartered in Manchester, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Gensia Sicor Pharmaceuticals, Inc. | Director/Board Member | ||
Parke, Davis & Co. LLC | Corporate Officer/Principal | ||
National Committee on United States-China Relations, Inc. | Director/Board Member | ||
Sanofi-Aventis (Singapore) Pte Ltd.
![]() Sanofi-Aventis (Singapore) Pte Ltd. Medical/Nursing ServicesHealth Services Part of Sanofi, Sanofi-Aventis (Singapore) Pte Ltd. is a healthcare and Singaporean pharmaceutical company that develops medicines and vaccines. The company is based in Singapore, Singapore. | Medical/Nursing Services | Chief Executive Officer | |
Nicoventures Trading Ltd.
![]() Nicoventures Trading Ltd. Industrial ConglomeratesProducer Manufacturing Nicoventures Trading Ltd. researches, develops, manufactures and delivers tobacco harm reduction products and services. The firm provides innovative and sustainable solutions to global problems arising from smoking and smoking-related illnesses. The company develops ortfolio of products and services focused on smoking cessation and harm reduction, including user-friendly nicotine delivery systems and patient-focused smoking cessation and support services. The company was founded by Christopher John Lord and David Thomas Newns in September 2008 and is headquartered in Manchester, the United Kingdom. | Industrial Conglomerates | Director/Board Member | |
NeRRe Therapeutics Ltd.
![]() NeRRe Therapeutics Ltd. Medical DistributorsDistribution Services NeRRe Therapeutics Ltd. provides clinical and pre clinical drugs for treatment of neuronal hypersensitivity. It develops neurokinin receptor antagonists acquired from GlaxoSmithKline. The company was founded by Emiliangelo Ratti and Mike Trower in 2012 and is headquartered in Stevenage, the United Kingdom. | Medical Distributors | Director/Board Member | |
BEIGENE, LTD. | Pharmaceuticals: Major | Director/Board Member | |
Sanofi Biotechnology SAS
![]() Sanofi Biotechnology SAS BiotechnologyHealth Technology Part of Sanofi, Sanofi Biotechnology SAS is a pharmaceutical and healthcare company based in Paris, France. The French company's engagement is to leverage the fast-changing innovative ecosystem to build stronger partnerships. Sanofi's senior leadership is accountable for ensuring they respect the highest standards of ethics and integrity. The CEOs of the company are Laurent Gilhodes, Mathias Thibault. | Biotechnology | Chairman | |
Orphalan SA
![]() Orphalan SA Pharmaceuticals: MajorHealth Technology GMP-Orphan SA engages in the research and development in biotechnology. It focuses on developing and designing drugs for life-threatening and rare diseases. The company was founded by Frederic Marin on July 18, 2011 and is headquartered in Paris, France. | Pharmaceuticals: Major | Director/Board Member | |
Aspire Pharma Ltd.
![]() Aspire Pharma Ltd. Pharmaceuticals: MajorHealth Technology Part of H.I.G. Capital LLC, Aspire Pharma Ltd. is a British company that licenses and develops products with innovative formulations, value for money for payors, and reliable supply agreements. The private company is based in Petersfield, UK. Aspire Pharma is present in the generics, speciality generics, branded medicines, and medical device sectors. The company was founded in 2009 by Graham Julian Fraser-Pye. The CEO is Richard Michael Condon. Aspire Pharma was acquired by H.I.G. Capital LLC on September 24, 2021. | Pharmaceuticals: Major | Founder | |
KaNDy Therapeutics Ltd.
![]() KaNDy Therapeutics Ltd. BiotechnologyHealth Technology KaNDy Therapeutics Ltd. engages in the provision of a treatment of chronic debilitating female sex-hormone related conditions. Its product is NT-814 a non-hormonal therapy to treat moderate to severe post-menopausal vasomotor symptoms. The company was founded by Dr. Mike Trower and Mary Kerr in 2017 and is headquartered in Stevenage, the United Kingdom. | Biotechnology | Director/Board Member | |
Dewpoint Therapeutics, Inc.
![]() Dewpoint Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Dewpoint Therapeutics, Inc. develops drugs. The company is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member | |
Aspire Pharma Holdings Ltd.
![]() Aspire Pharma Holdings Ltd. Medical DistributorsDistribution Services Aspire Pharma Holdings Ltd. is a holding British company founded in 2014. The private company is based in Godalming, UK. The company's subsidiaries market pharmaceutical products. | Medical Distributors | Director/Board Member Director/Board Member Director/Board Member | |
NeRRe Therapeutics Holdings Ltd.
![]() NeRRe Therapeutics Holdings Ltd. Miscellaneous Commercial ServicesCommercial Services NeRRe Therapeutics Holdings Ltd. is a British biotechnology company founded in 2017. The private company is based in Stevenage, UK. The company is engaged in research and development of biotechnology. | Miscellaneous Commercial Services | Director/Board Member | |
Juno Pharmaceuticals Corp.
![]() Juno Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Juno Pharmaceuticals Corp. specializes in bringing complex and high-value generic and biosimilar products to the Canadian market. The company is based in Mississauga, Canada, and has subsidiaries in Canada. The Juno management team possesses decades of pharmaceutical industry experience and has a track record of driving strategic growth through the identification of niche products and disciplined construction of robust product pipelines. Juno licenses and acquires specialized pharmaceutical products that have limited competitors and inherent barriers to market entry. The Canadian company was founded in 2019, and Mark Mantel has been the CEO of the company since 2022. | Pharmaceuticals: Major | Director/Board Member | |
Aphl 2 Ltd.
![]() Aphl 2 Ltd. Miscellaneous Commercial ServicesCommercial Services Aphl 2 Ltd. is a British company that provides business support services. The private company is based in Godalming, UK. The company was founded in 2018. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
APHL 1 Ltd.
![]() APHL 1 Ltd. Miscellaneous Commercial ServicesCommercial Services APHL 1 Ltd. is a British company that provides business support services. The private company is based in Godalming, UK. The company was founded in 2018. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
AvenCell Therapeutics, Inc.
![]() AvenCell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AvenCell Therapeutics, Inc. is a biopharmaceutical company that develops immunotherapies to treat cancers. The private company is based in Cambridge, MA and has subsidiaries in Germany. Andrew D. Schiermeier has been the CEO of the company since 2021. | Pharmaceuticals: Major | Chairman | |
BENEVOLENTAI | Biotechnology | Director/Board Member | |
CELLNOVO | Medical Specialties | Corporate Officer/Principal |
Statistik
International
Vereinigte Staaten | 20 |
Vereinigtes Königreich | 19 |
Frankreich | 5 |
Deutschland | 3 |
Luxemburg | 3 |
Sektoral
Health Technology | 30 |
Commercial Services | 6 |
Consumer Services | 6 |
Finance | 5 |
Distribution Services | 3 |
Operativ
Director/Board Member | 52 |
Corporate Officer/Principal | 19 |
Chairman | 8 |
Chief Executive Officer | 7 |
Chief Tech/Sci/R&D Officer | 4 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Rakesh Chhaganlal Tailor
- Unternehmensverbindungen